This article is more than 5 years old. Information may no longer be current.
VIDEO: Physicians should recognize predictors of bleeding in hospitalized patients with cancer
Click Here to Manage Email Alerts
SAN DIEGO — Alok A. Khorana, MD, spoke with HemOnc Today at the ASH Annual Meeting and Exposition about a study designed to determine which hospitalized patients with cancer are most likely to experience bleeding, and the factors that may predict bleeding risk.
“It is important we study this because [patients with cancer] are at risk for both blood clots and for bleeding,” said Khorana, professor of medicine at Cleveland Clinic Lerner College of Medicine, vice chair for clinical services of Taussig Cancer Institute and director of the gastrointestinal malignancies program at Cleveland Clinic. “The abstract is an attempt at understanding who are the patients that are going to bleed. And if we can predict those patients, we can appropriately use thromboprophylaxis to prevent clots.” – by Kristie L. Kahl
Reference:
Patell R, et al. Abstract 529. Presented at: ASH Annual Meeting and Exposition; Dec. 3-6, 2016; San Diego.
Disclosure: Khorana reports consultant roles with Amgen, Bayer, Halozyme, Janssen Scientific Affairs, LEO Pharma, Pfizer, Roche and Sanofi; honoraria from Amgen, Bayer, Halozyme, Janssen, LEO Pharma, Pfizer, Roche and Sanofi; and research funding from Amgen, Janssen Scientific Affairs and LEO Pharma.